High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer
Aaron J. Stonestrom(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Sebastià Franch‐Expósito(Memorial Sloan Kettering Cancer Center), Simon Mantha(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Abhinita Mohanty(Memorial Sloan Kettering Cancer Center), Sean M. Devlin(Memorial Sloan Kettering Cancer Center), Ronak Shah(Memorial Sloan Kettering Cancer Center), Kamal Menghrajani(Memorial Sloan Kettering Cancer Center), Jennifer H. Milbank(Memorial Sloan Kettering Cancer Center), Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Barbara Spitzer(Memorial Sloan Kettering Cancer Center), Justin Jee(Memorial Sloan Kettering Cancer Center), Xiaodi Wu(Washington University in St. Louis), Pablo Sánchez Vela(Memorial Sloan Kettering Cancer Center), A. Rose Brannon(Unknown), Swara Y. Patel(Hunter College), Ryan Ptashkin(Memorial Sloan Kettering Cancer Center)
Cited by 13
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k